Rigel Pharmaceuticals (RIGL) Change in Inventory (2018 - 2026)
Rigel Pharmaceuticals (RIGL) posted quarterly Change in Inventory of $581000.0 for Q1 2026, up 141.12% year-over-year from $240960.7 in Q1 2025, and up 151.37% quarter-over-quarter from -$1.1 million in Q4 2025.
Rigel Pharmaceuticals (RIGL) Change in Inventory (2018 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Change in Inventory history runs 9 years deep, the most recent figure standing at $581000.0 for Q1 2026.
- In Q1 2026, Change in Inventory rose 141.12% year-over-year to $581000.0; the TTM figure through Mar 2026 stood at $7.6 million (up 270.02% YoY), while the FY2025 annual figure was $5.6 million, up 837.57% from the prior year.
- Change in Inventory for Q1 2026 stood at $581000.0, up from -$1.1 million in the prior quarter.
- The five-year high for Change in Inventory was $8.4 million in Q2 2025, with the low at -$3.3 million in Q3 2024.
- The 5-year median for Change in Inventory is -$188000.0 (2025), against an average of $391588.2.
- The sharpest annual moves came in 2023 and 2024: Change in Inventory surged 1640.18% in 2023, then tumbled 1090.04% in 2024.
- Rigel Pharmaceuticals' Change in Inventory stood at $2.0 million in 2022, then tumbled by 227.63% to -$2.5 million in 2023, then increased by 23.94% to -$1.9 million in 2024, then jumped by 41.25% to -$1.1 million in 2025, then surged by 151.37% to $581000.0 in 2026.
- Business Quant data shows RIGL's Change in Inventory at $581000.0 in Q1 2026, -$1.1 million in Q4 2025, and -$188000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 47.15 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,188.52 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -280,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Rigel Pharmaceuticals | 795.39 Mn | 700.06 Mn | 70.18 Mn | 3.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.26 Mn |
| Jun 30, 2026 | 3.26 Mn |
| Mar 31, 2026 | 581,000.00 |
| Mar 31, 2026 | 581,000.00 |
| Dec 31, 2025 | -1.13 Mn |
| Dec 31, 2025 | -1.13 Mn |
| Sep 30, 2025 | -188,000.00 |
| Sep 30, 2025 | -188,000.00 |
| Jun 30, 2025 | 8.37 Mn |
| Jun 30, 2025 | 8.37 Mn |
| Mar 31, 2025 | -1.41 Mn |
| Mar 31, 2025 | -1.41 Mn |
| Dec 31, 2024 | -1.93 Mn |
| Dec 31, 2024 | -1.93 Mn |
| Sep 30, 2024 | -3.34 Mn |
| Sep 30, 2024 | -3.34 Mn |
| Jun 30, 2024 | 2.20 Mn |
| Jun 30, 2024 | 2.20 Mn |
| Mar 31, 2024 | 2.31 Mn |
| Mar 31, 2024 | 2.31 Mn |